ZLAB (Zai Lab) Cash per Share: $5.96 (As of Mar. 2026)

What is Zai Lab Cash per Share?

Zai Lab ZLAB +3.20% 64 Cash per Share is $5.96 as of Mar. 2026. GuruFocus rates ZLAB with a GF Score™ of 64/100 and a GF Value™ of $30.30 (Possible Value Trap). The stock has 8 warning signs investors should review.

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Zai Lab's Cash per Share for the quarter that ended in Mar. 2026 was $5.96.

Zai Lab (NAS:ZLAB) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

Zai Lab Cash per Share Related Terms

Zai Lab Cash per Share Historical Data

* Premium members only.

The historical data trend for Zai Lab's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zai Lab Cash per Share Chart

Zai Lab Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Cash per Share

Get a 7-Day Free Trial

14.76

10.50

8.30

7.24

6.23

Zai Lab Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Cash per Share	Get a 7-Day Free Trial															6.99	6.66	6.49	6.23	5.96

64GF Score

Zai Lab Ltd ZLAB

Cash per Share is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Zai Lab Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Zai Lab's Cash per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	689.573	/	110.6
	=	6.23

Zai Lab's Cash per Share for the quarter that ended in Mar. 2026 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	661.316	/	111.0
	=	5.96

Frequently Asked Questions Learn more about Cash per Share →

What does a Cash per Share of $5.96 mean?

Zai Lab (ZLAB) has a Cash per Share of $5.96 as of Mar. 2026. Cash per share is the per-share value of a company's available cash. View historical data for Zai Lab and its competitors.

Is Zai Lab's Cash per Share too high?

Zai Lab's current Cash per Share is $5.96. Overall, Zai Lab has a GF Score™ of 64/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does Zai Lab's Cash per Share compare to STOK and ADMA?

Zai Lab's Cash per Share of $5.96 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Cash per Share for a Biotechnology company?

A good Cash per Share depends on the Biotechnology industry context. However, Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Cash per Share mean?

A high Cash per Share can signal that a stock is expensive relative to its fundamentals. Cash per share is the per-share value of a company's available cash. View historical data for Zai Lab and its competitors. Zai Lab's current Cash per Share is $5.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Zai Lab stock overvalued right now?

Based on GuruFocus' analysis, Zai Lab (ZLAB) is currently considered Possible Value Trap. The stock's GF Value™ is $30.30, compared to a current price of $19.00 — trading 37.3% below its estimated fair value. The current Cash per Share is $5.96. Zai Lab's overall GF Score™ is 64/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Cash per Share calculated?

Cash per Share is calculated from a company's financial statements. For Zai Lab (ZLAB), the current Cash per Share is $5.96 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zai Lab (ZLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Zai Lab stock appears to be undervalued. The current stock price of $19.00 is trading 37.3% below its estimated GF Value™ of $30.30. GuruFocus considers Zai Lab to be Possible Value Trap.

Key valuation signals for ZLAB:

Cash per Share: $5.96
GF Value™: $30.30 vs. price of $19.00 (37.3% below fair value)
GF Score™: 64/100 with 8 warning signs

No single metric tells the full story. See the ZLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zai Lab Business Description

Industry Healthcare Biotechnology

Comparable Companies STOK ADMA VRDN NUVB HRMY ATAI GHRS KARD PGEN RAPP VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Other Exchanges 09688:Hong Kong 1ZLB:Germany

Address 899 Halei Road, Building B, Pudong, Shanghai, CHN, 201203

Website https://www.zailaboratory.com

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.

64GF Score

Get the complete analysis for ZLAB

Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$19.00

Price

$30.30

GF Value

View ZLAB Analysis

See Cash per Share data for all stocks →